Singer G M, Lijinsky W, Buettner L, McClusky G A
Cancer Res. 1981 Dec;41(12 Pt 1):4942-6.
Nitrosomethylalkylamines with chain lengths from C4 (n-butyl-) to C14 (n-tetradecyl-) were each administered in three rats at doses equimolar with 12 mg of the butyl compound. All of the compounds administered to rats at this dose, twice a week for 30 weeks, induced tumors in 100% of the animals. Some of the compounds with even-numbered alkyl chains induced bladder tumors, and a connection was sought with the metabolites of these excreted in urine. The pooled 24-hr urine was extracted with ethyl acetate before and after acidification to provide a neutral fraction and a fraction containing nitrosoamino acids. The fraction containing the acids was analyzed by capillary gas chromatography and by gas chromatography-mass spectrometry after esterification with diazomethane; the neutral fraction was analyzed similarly. The principal metabolite of the nitrosoamines with odd-numbered chains was found in the acidic fraction and was identified as nitrosomethyl-2-carboxy-ethylamine. There were several acids in the mixtures derived from the nitrosamines with even-numbered chains, nitrososarcosine and nitrosomethyl-3-carboxypropylamine being the major components. There was no trend in the yields of the nitrosamino acids that could be correlated with the differences in carcinogenic potency between the nitrosamines; the maximum yield of acids was more than 30% (from the tetradecyl compound). The principal component of the neutral fraction (less than or equal to 1% of the nitrosomethylalkylamine administered) was nitrosomethyl-2-oxopropylamine. The yield of this compound increased with length of the even-numbered chain nitrosamines.
链长从C4(正丁基-)到C14(正十四烷基-)的亚硝基甲基烷基胺,分别以与12毫克丁基化合物等摩尔的剂量给予三只大鼠。以该剂量每周两次给大鼠给药30周,所有给予的化合物均在100%的动物中诱发肿瘤。一些具有偶数烷基链的化合物诱发膀胱肿瘤,并研究了其与尿液中排泄的这些化合物代谢产物的关联。将24小时合并尿液在酸化前后用乙酸乙酯萃取,以得到中性部分和含有亚硝基氨基酸的部分。含有酸的部分经毛细管气相色谱分析,并在用重氮甲烷酯化后用气相色谱-质谱分析;中性部分也进行类似分析。发现奇数链亚硝基胺的主要代谢产物存在于酸性部分,鉴定为亚硝基甲基-2-羧基乙胺。偶数链亚硝基胺衍生的混合物中有几种酸,其中主要成分是亚硝基肌氨酸和亚硝基甲基-3-羧基丙胺。亚硝基氨基酸的产量没有与亚硝基胺致癌效力差异相关的趋势;酸的最大产量超过30%(来自十四烷基化合物)。中性部分的主要成分(占给予的亚硝基甲基烷基胺的1%以下)是亚硝基甲基-2-氧代丙胺。该化合物的产量随偶数链亚硝基胺链长的增加而增加。